Blog

  • From residency to rocketship—how SmarterDx became a healthcare AI success story

    From residency to rocketship—how SmarterDx became a healthcare AI success story

    Clinicians are stepping into the entrepreneurial spotlight as AI transforms healthcare at breakneck speed—with rapid buy-in happening across the industry and providers leading the way, experimenting and implementing AI across multiple use cases. Consider SmarterDx: in just a few years, this healthcare AI rocketship has redefined how hospitals analyze patient records to unlock new revenue, elevate care quality, and streamline operations.

    “SmarterDx is an AI rocketship in healthcare.”

    The journey of Dr. Mike Gao (CEO) and Dr. Joshua Geleris (Chief Product and Data Science Officer), SmarterDx’s co-founders, was anything but straightforward. Rising from frontline medicine to industry leaders meant navigating clinical demands, pandemic turbulence, and the notoriously tough healthcare sales cycle. Their perseverance paid off, culminating in SmarterDx’s rapid ascent and recent acquisition by New Mountain Capital.

    Mike and Josh’s shared experience as practicing physicians exposed them to the systemic revenue leaks and documentation gaps plaguing hospitals. This clinical credibility empowered them to design AI that integrates seamlessly into hospital workflows—delivering value without disruption.

    We sat down with Mike and Josh to distill their hard-earned lessons for the next generation of healthcare AI founders. Their first piece of advice? “Don’t start a company during a global pandemic,” Josh quipped.

    As we looked back on Bessemer’s relationship with SmarterDx since our Series A investment, the founders unpacked how to navigate the eccentricities of healthcare, build enduring co-founder relationships, and master founder-led sales while scaling with discipline.

    The SmarterDx story is a blueprint for clinicians and technologists alike who are ready to build the future of healthcare—one patient record at a time.

    Takeaways on scaling a healthcare AI company from SmarterDX

    • Listening to customers drives product evolution
    • Maintaining patience and persistence is crucial with longer sales cycles
    • Founders need to lead the charge in early-stage sales
    • Talent is everything—focus on hiring quality

    Innovating in healthcare AI with clinical expertise and customer care

    Mike and Josh first crossed paths during their residency at NewYork-Presbyterian, quickly discovering a powerful combination: Mike’s healthcare systems acumen and customer empathy paired with Josh’s technical problem-solving and product vision as they frequently worked together on hospital digital transformation and artificial intelligence innovation efforts. Together, they forged a partnership grounded in mutual respect and a shared conviction that supercharging patient care is possible through smarter, more efficient hospital systems.

    At Bessemer, we saw the duo brought not only deep domain expertise and technical fluency to SmarterDx, but also a rare persistence and grit—traits we see in the very best founders and frontline clinicians. As Josh put it, “Mike has a talent for delivering a level of white glove service to customers I’ve never seen before. I’m still in awe of how he can instantly understand what they need and ensure we deliver on that promise.” Mike, in turn, admires Josh’s long-term product vision and technical depth: “Josh doesn’t just optimize for the short term—and he can architect an entire data pipeline for client onboarding, a level of engineering skill that’s incredibly rare among physicians.”

    Their experience offers a lesson for co-founders everywhere. Early on, Mike and Josh recognized the importance of owning distinct parts of the business. They naturally gravitated toward a division of labor: Mike as the external-facing “white glove” customer partner and sales lead, and Josh as the internal anchor for product, operations, and technical support. The key to their success has been complementary skills, deep mutual trust, and a willingness to stay hands-on across functions—setting the standards and ensuring quality as the company scaled at warp speed.

    SmarterDX’s response to COVID: Lessons in resilience for startups

    In their industry, every startup faces long sales cycles, fragmented buyers, and deceptively narrow markets—but a global pandemic forced Mike and Josh to rethink momentum from the ground up.

    “In the early days, we saw immediate traction—two out of our first three hospitals wanted to move forward,” Mike recalled. “Then COVID hit, and a Chief Medical Officer told us, ‘I have to deal with this coronavirus. Can I get back to you in a couple weeks?’ That hospital became a customer three years later—a stark reminder of how much this industry is at the mercy of macro events and just how drawn-out sales cycles can be.”

    Of course, a few weeks became months with COVID, and so did the potential customer conversations. Even after the initial crisis, hospitals remained unstable and hesitant to engage with new vendors, leaving Mike and Josh in a year-and-a-half holding pattern. They returned to serve as hospitalists, waiting patiently until the market was ready to re-engage.

    This experience highlights a core founder principle: master the rhythm of when to push, when to pause, and the patience required to build trust in healthcare. Customer relationships were the engine of innovation—nuanced feedback from early partners drove product pivots and go-to-market refinement. Their adaptability, relentless customer focus, and knowing how to weather slow periods and seize momentum when it returns set SmarterDx apart and fueled their breakout growth.

    Founder-led sales for early-stage success

    Winning in healthcare starts with founders driving early sales to uncover real product-market fit. SmarterDx’s team discovered that selling directly to customers revealed what resonated—and what didn’t.

    “Early on, we pitched a concurrent CDI solution, but customer feedback pushed us to pivot to post-discharge analysis, focusing only on net-new findings,” shared Mike on developing their SmarterPrebill™ solution. “We learned that offering too many options confused buyers; simplifying our pitch to a single, clear value proposition was the breakthrough.”

    But the real test? When you can run a clear-cut, 20-minute call that consistently lands—only then is your sales message ready to scale beyond the founders.

    As Josh put it, “In healthcare, you only get a handful of shots with potential customers, and each conversation yields just a sliver of feedback—maybe one or two questions. But those questions are gold. Mike excelled at obsessively analyzing every customer query, connecting insights across months, and refining both pitch and product. If we’d just kept selling what we thought was best, we’d have missed our breakthrough. By triangulating these subtle signals, we discovered the core product and go-to-market engine that fueled our growth.”

    Three rules for founder-led sales:

    • Treat every customer conversation as a learning opportunity.
    • Obsessively analyze every question or objection to refine your pitch and product.
    • Don’t scale sales until you have a repeatable, teachable motion that lands.

    What the SmarterDx founders wish they knew at the early stage

    As our conversation wrapped up, Josh shared a moment of vulnerability:

    “On a podcast, I was listening to Jensen Huang from NVIDIA, and when asked what kind of company he’d start today, he said, ‘I wouldn’t do it. It’s too hard.’ I nearly cried walking my dog—it resonated so deeply. Building a company is one of the hardest things you’ll ever do. My advice: be prepared, go all in, and know it’s not for the faint of heart.”

    From their trials, Mike and Josh distilled these essential lessons for early-stage founders:

    1. Listening to customers drives product evolution: Actively listen to your customers and use their feedback to refine your product and value proposition, especially during longer sales cycles.
    2. Maintaining patience and persistence is crucial with longer sales cycles: Recognize the inflection point. In healthcare, product-market fit is often hindered by long sales cycles. But when growth accelerates, founders must adapt quickly or risk being outpaced by demand. Hypergrowth—like scaling 600% a year—means even rapid hiring can’t keep up.
    3. Founders need to lead the charge in early-stage sales: Before product-market fit, stay scrappy, do everything yourself, and iterate fast. Once you hit product-market fit, shift gears—resource aggressively to capture the market. Don’t underinvest when the signal is clear.
    4. Talent is everything—focus on hiring quality: Maintain a relentless focus on hiring quality, even when you’re understaffed. The long-term payoff of a high-talent bar far outweighs the temptation to hire quickly just to fill seats.

    SmarterDx’s journey from early stage to acquisition is a case study in the power of “compounding learning”—years of domain immersion and customer discovery create an unshakeable foundation for scale. Mike and Josh’s unwavering focus on solving real problems, listening to customers, and executing with discipline turned SmarterDx into one of healthcare AI’s standout successes. We’re so grateful to them both for letting Bessemer be part of their exceptional journey.

    Continue Reading

  • UK-Pakistan Trade Dialogue Mechanism launched in London – RADIO PAKISTAN

    1. UK-Pakistan Trade Dialogue Mechanism launched in London  RADIO PAKISTAN
    2. London: Federal Minister for Commerce, Jam Kamal Khan, held a meeting with Lord Wajid Khan, UK Minister of Housing, Communication, and Local Government, in London today. High Commissioner Dr. Mohammad Faisal was also present.  Ptv.com.pk
    3. UK, Pakistan launch trade dialogue to deepen economic ties  The Express Tribune
    4. Pakistani commerce minister embarks on ‘pivotal’ UK visit to deepen economic ties  Arab News
    5. PFC CEO seeks stronger Pak-UK trade ties to boost socio-economic development  Associated Press of Pakistan

    Continue Reading

  • Study reveals key role of Egr-1 in controlling autoimmune diseases

    Study reveals key role of Egr-1 in controlling autoimmune diseases

    Autoimmune diseases, like multiple sclerosis result when the body’s immune system starts to attack its own cells. Regulatory T cells, a subtype of T cells play a critical role in suppressing these attacks. Now, a study published in Research (SPJ) sheds light on the potential role of the Egr-1 gene in promoting these protective cells through the activation of the Foxp3 protein. This finding unlocks promising avenues for managing autoimmune conditions via Egr-1 activation.

    Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect millions of people worldwide. These conditions arise when the body’s immune system fails to distinguish between “self” and “foreign” cells, and mistakenly attacks its own healthy cells, resulting in persistent inflammation and tissue damage. Central to these autoimmune responses are CD4+ T cells, a class of immune cells that can either promote or suppress the condition.

    Regulatory T cells (Treg) are a special subtype of CD4+ T cells that act as the immune system’s peacekeepers. Treg cells, marked by protein Foxp3, help in suppressing harmful immune responses. However, when the function of Treg cells is compromised, as seen in cases of MS and IBD, the immune response is dominated by the Th1 and Th17 cells (other CD4+T cell subtypes), which promote inflammation, further worsening the disease symptoms. Therefore, boosting the development and activity of Treg cells is emerging as a promising therapeutic approach, but the mechanisms underlying its effective regulation remain unclear.

    In pursuit of a deeper understanding of these mechanisms, a team of Chinese scientists led by Dr. Xiaojun Wu and Dr. Fei Huang from the Shanghai Key Laboratory of Compound Chinese Medicines, SHUTCM, China, and Dr. Weidong Pan from the Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China, explored the role of Early Growth Response Gene 1 (Egr-1) in promoting the activity of Treg cells. The study was conducted in a well-established animal model of MS, called experimental autoimmune encephalomyelitis (EAE), to confirm the mechanisms. The findings of this study were published in Volume 8 of Research on April 15, 2025.

    Elaborating more, Dr. Wu, the lead author of this study, says “We started by screening the genes that appeared different between mice with mild and severe EAE.” Further, he adds, “Among the top identified genes in CD4+ T cells, Egr-1 stood out as significantly downregulated in severe disease.”

    After identifying Egr-1 as a regulatory gene, the team assessed its role by using genetically engineered mice lacking Egr-1 in CD4+ T cells. These mice were induced with EAE and tracked for disease progression. The researchers also analyzed the immune cell compositions in the spleen, lymph nodes, and central nervous system of these mice.

    The mice lacking Egr-1 showed worse disease, fewer Treg cells, and more inflammatory TH17 and TH1 cells” explains Dr. Huang.

    The researchers also conducted additional in vitro experiments. By analyzing isolated human CD4+ T cells from MS patients and healthy donors, they confirmed that both Egr-1 and Foxp3 levels were reduced in patient samples. Further, to determine whether Egr-1 directly regulates Foxp3, the researchers used chromatin immunoprecipitation, which revealed that Egr-1 binds to the Foxp3 promoter. Additionally, using luciferase reporter assays, they also confirmed that Egr-1 binding increases Foxp3 gene activity. They then traced the pathway to TGF-β (Transforming Growth Factor Beta) signaling via the Raf/Mek/Erk cascade, which activates Egr-1.

    We identified a unique mechanism of Egr-1,” explains Dr. Pan, “First, TGF-β activates the Raf/Mek/Erk cascade, which activates Egr-1. Egr-1 then directly binds to the Foxp3 promoter to enhance its expression, bypassing the classical Smad3-dependent pathway.”

    What’s more, the researchers also investigated the effect of a natural compound, Calycosin, which acts as an Egr-1 agonist. Treatment with calycosin restored Treg cell functions and improve clinical outcomes in mice with EAE, but only in those with functional Egr-1.

    Overall, the study underscores the essential role of Egr-1 in Treg cell development and function, identifying it as a central molecular switch in immune regulation. By elucidating its mechanism and validating the effect of a natural Egr-1 agonist, the study suggests that targeting Egr-1 may offer a promising treatment strategy, potentially transforming therapeutic approaches to autoimmune diseases.

    Source:

    Journal reference:

    Yang, L., et al. (2025). Early Growth Response Gene 1 Benefits Autoimmune Disease by Promoting Treg Cell Differentiation as a regulator of Foxp3. Research. doi.org/10.34133/research.0662.

    Continue Reading

  • Here’s how the pros are investing in the gold rally

    Here’s how the pros are investing in the gold rally

    Continue Reading

  • Emily Ratajkowski on ‘Too Much’ and Parasocial Relationships

    Emily Ratajkowski on ‘Too Much’ and Parasocial Relationships

    SPOILER ALERT: This interview contains spoilers for “Too Much.”

    Emily Ratajkowski has returned to acting after making headlines in 2023 for firing her team and leaving the business. At the time, she lamented the feeling of making herself “digestible to powerful men in Hollywood,” so it’s no surprise that her first new project is not only created by a woman, but by her friend: Lena Dunham.

    “Too Much,” Dunham’s new Netflix comedy series, follows Jessica (Megan Stalter) in the months following her breakup from her ex-boyfriend Zev (Michael Zegen). Ratajkowski plays Wendy, Zev’s new girlfriend, who is an influencer, and the constant stream of Instagram photos from Zev and Wendy’s happy life together drives Jessica crazy. She drunkenly breaks into their New York apartment to confront them one night, while Wendy does tell Jessica she seems crazy, she’s surprisingly calm and generous during the encounter.

    Throughout the series, Jessica records videos addressed to Wendy that she uploads to a private Instagram account. It’s meant to be an outlet for her to cope with her breakup, but one day, she accidentally makes the account public and the videos go viral. Soon after, Wendy reaches out to Jessica and asks to meet up. Rather that discuss the videos, Wendy asks Jessica for details on the timeline of her breakup with Zev, and together, they realize Zev was lying to them both. They bond over the way Zev treated them and wish each other well, with Wendy even offering Jessica advice about her current relationship with Felix (Will Sharpe).

    Ratajkowski spoke to Variety about playing “the other woman.”

    You and Lena Dunham have been friends for a long time. What were your initial thoughts when she told you about this role?

    We’ve always had a lot of conversations around women that you feel like you’re connected to in strange ways, but you don’t totally know them. And how, as we’ve gotten older, we’ve always been pro-sisterhood, but that when you’re younger, you don’t necessarily do that, because you’re intimidated or because it’s a defense mechanism.

    Do you relate to Jessica as well as Wendy in that way? Having those ideas about other women, but having others project onto you as well?

    I mean, I’ve been Jessica and I’ve been Wendy. I think, probably, that’s true for most people. At first, Lena had written her as a lawyer, and I was like, “I want her to be a little bit more hateable.” She was such a smart, perfect, amazing person who was, like, posting social justice stuff online. And I was like, “I really want this girl to be an influencer, and I don’t think that’s leaning into stereotypes, because we’re going to get to know her in a better way, but I think the payoff could be really great at the end.” It’s a weird time we live in. 30 years ago, if your ex-boyfriend got a new girlfriend, you’d maybe meet her once, or see a picture once, but now you can have access to their everyday goings-on. And I think that can really fuck with your brain, because it’s someone that you share a person with or history with, and there’s a connection, but they’re behind a screen. So I think it was really cool the way that Lena explored that.

    Tell me more about wanting to make her feel hateable. Was the purpose of that to help validate the way Jessica’s feeling?

    No, I just liked the idea that people are like, “Oh, of course, an influencer.” There’s just a lot of judgment for women who post a lot online, or play into the attention economy. And I personally didn’t think that made her more hateable, but I could see why someone else would. Somebody who was well-meaning was like, “Let’s make her so smart.” I’m like, “She is so smart. But that doesn’t mean she has to be a lawyer, right?” And she also is just in opposition to Jessica in so many ways. She’s really cool and collected, and she’s creatively fulfilled, and all these things that Jessica can’t relate to. But then, of course, we get to see that she’s also this dynamic character in the final episode.

    Until that final episode, we only see Wendy through the perspective of Jessica, who imagines that she and Zev have a picture-perfect life together. But obviously, Wendy’s relationship with Zev had big problems. How do you imagine that time?

    I [thought of Wendy] as a girl who was living with roommates and who had had serious relationships before, but maybe of a certain kind. She was like, “Oh, this is the dorky guy. He’s safe.” Which happens with women in your 20s and your 30s. You try out different tropes, because you’re like, “Maybe this archetype! The sweet guy! Or the nerdy guy! They’re going to be different! I’ll be safe from these things I’ve experienced before.” My vision of Wendy was that she was like, “He’s such a nice Jewish boy who has great taste in music, and sees me for who I am all the things that I love to do. And we can talk about all the cool shit that I want to talk about. He’s cozy.” And, of course, he turns out not to be that way at all.

    And how do you think Wendy was imagining Jessica? She was definitely being told one story by Zev, but she seems to have had her own perspective too.

    I’m sure she also has stalked Jessica [online]. There’s probably, like, three girls whose lives she checks in on regularly. And she does have a crazy experience with Jess, which obviously validates a lot of what Zev was probably telling her. When she breaks in, I think she’s of two minds. She’s like, “Okay, you’re kind of crazy, and I’ve heard all these crazy things about you. But also, you’re just crashing out and not handling it well.” She’s more generous — although even Jess, throughout the whole thing, never falls into thinking [Wendy] is stupid. There’s some semblance of respect. I think both of the characters have that. I always say, if a guy tells you all of his ex-girlfriends are crazy, that’s a red flag.

    After having Jessica break into the apartment in the middle of the night and then later seeing these private videos Jessica recorded about her, why does Wendy still want to meet up with her? How is she comfortable with that?

    With being gaslit, there’s always a feeling. Wendy moved into this apartment, and she was told one story that was not true, but there were signs — the Cupcake rosé, the face wash, stuff that didn’t add up. And it can be a really weird feeling when your biggest fears are validated. I imagine Wendy in this moment being like, “Oh, wow. All the things that I was not wanting to believe, because I didn’t want to believe my partner would be lying to me, now I get to see them. And as horrible as that is for her relationship, she has a really great perspective on it, which is, “Now I know the truth, and that’s better than living this other way.”

    How did it feel to shoot the meet-up with Jessica? It has such a different tone from the rest of your appearances in the season, which happen from Jessica’s perspective.

    I absolutely loved it. It was the first scene I shot for the show, and it was my first time being directed by a woman, and by my friend [Dunham]. Meg and I had just met, and even though we exchanged a few stories, it was sort of fresh. That felt really nice. I felt like it helped inform the scene, the fact that it was the first day, and we had just so much fun shooting it. Meg is amazing at improv. She just goes for it. So there were takes that were very funny, but there were some that were more tender, and it was just a pleasure.

    After they finish talking about Zev, why do you think Wendy goes out of her way to give Jess advice about her new relationship?

    I think she’s in a very reflective moment. Wendy’s the type of girl to do a lot of therapy, and I imagine that she’s like, “Alright, I’m going to move on with my life. I’m open to love.” She’s in a very wise place, which can happen — I think you can feel like a zen master while crashing out during a breakup. And she’s obviously seen Jess’ videos. She’s had a real life experience of her breaking into her house, so she’s putting boundaries around her friendship and being like, “I’m not trying to hang out with you all the time, but if you’re asking me, here’s some of the ways that I’m living my life.”

    If “Too Much” is renewed, do you see a world where you’d return to this world? Do you see a future where Wendy and Jessica continue to cross paths?

    I definitely do. And Lena and I have had fun little convos about what that would look like. I mean, who knows? But I absolutely loved playing her. The world felt so clear to me. I know [Wendy] well — I feel like I could run into her on the street in Brooklyn. So it’d be very fun to return to her.

    You’ve spoken in the past about feeling pigeonholed in Hollywood and cast based on your looks rather than your substance. Here, you get to subvert that, with Wendy being portrayed as just another hot girl on the internet until we get deeper and see who she really is. Did you feel like you were working through those hard moments in your career through this role?

    Lena was the first person who published my writing, on Lenny Letter, but she knew about me from Instagram. I’ve had a lot of experiences, with Lena specifically, where she has seen past surface level things and given me so many opportunities. When I shot [“Too Much”], I was about to turn 33. I’m a grown ass woman, with a child, and it just felt very natural and right to be doing the kind of roles and working with the kind of people who share the ideas I do around women and respect. So I wasn’t really working anything, but it felt really nice.

    This interview has been edited and condensed.

    Continue Reading

  • Nvidia says it hopes to resume H20 AI chip sales to China ‘soon’

    Nvidia says it hopes to resume H20 AI chip sales to China ‘soon’

    Nvidia CEO Jensen Huang attends a roundtable discussion at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris on June 11, 2025.

    Sarah Meyssonnier | Reuters

    Nvidia announced Tuesday that it hopes to resume sales of its H20 general processing units to clients in China, saying that the U.S. government had assured the company would be granted licenses.

    Nvidia’s sales of the H20 AI chips, which had been designed specifically to keep them out of export controls on China, were halted in April.

    “The U.S. government has assured NVIDIA that licenses will be granted, and NVIDIA hopes to start deliveries soon,” the company said in a statement.

    Nvidia CEO Jensen Huang in recent months has ramped up his lobbying against export controls, arguing that they inhibited American tech leadership. In May, Huang said chip restrictions had already cut Nvidia’s China market share nearly in half.

    The potential change in U.S. stance follows a meeting between Huang and U.S. President Donald Trump last week. During the talks, Huang had reaffirmed Nvidia’s support for the administration’s job creation and onshoring efforts, as well as the aim for America to lead in global AI, the company said.

    Washington and Beijing last month agreed to a preliminary trade framework that allowed relaxing rare-earth export controls by China and easing of tech export curbs by the U.S.

    Huang also announced a new “fully compliant” GPU, NVIDIA RTX PRO, saying it was ideal for smart factories and logistics.

    Since May, reports had indicated that Nvidia was working on a new AI chip for the China market, which would be less advanced than the H20. 

    However, the potential resumption of H20 chips to China comes as a surprise, Ray Wang, research director of semiconductors, supply chain and emerging technology at Futurum Group, told CNBC.

    “The lifting of the H20 ban marks a significant and positive development for Nvidia, which will enable the company to reinforce its leadership in China,” Wang said.

    “The resumption of H20 shipments — alongside the upcoming rollout of new export control-compliant AI chips for the Chinese market — should serve as a fresh growth catalyst in the coming quarters,” he added.

    Meanwhile, Nvidia confirmed that Huang was in China where he has met with government and industry officials to discuss the benefits of AI and ways for researchers to advance safe and secure AI. 

    Continue Reading

  • Poet, Star of Come See Me in the Good Light Was 49

    Poet, Star of Come See Me in the Good Light Was 49

    Andrea Gibson, a celebrated poet and performance artist who through their verse explored gender identity, politics and their 4-year battle with terminal ovarian cancer, died Monday at age 49.

    Gibson’s death was announced on social media by their wife, Megan Falley. Gibson and Falley are the main subjects of the documentary Come See Me in the Good Light, winner of the Festival Favorite Award this year at the Sundance Film Festival and scheduled to air this fall on Apple TV+.

    “Andrea Gibson died in their home (in Boulder, Colorado) surrounded by their wife, Meg, four ex-girlfriends, their mother and father, dozens of friends, and their three beloved dogs,” Monday’s announcement reads in part.

    The film — exploring the couple’s enduring love as Gibson battles cancer — is directed by Ryan White and includes an original song written by Gibson, Sara Bareilles and Brandi Carlile. During a screening at Sundance in January that left much of the audience in tears, Gibson said they didn’t expect to live long enough to see the documentary.

    Andrea Gibson and Megan Falley appear in Ryan White’s feature documentary, ‘Come See Me in the Good Light,’ an official selection of the 2025 Sundance Film Festival.

    Courtesy of Sundance Institute | photo by Brandon Somerhalder

    Tributes poured in Monday from friends, fans and fellow poets who said Gibson’s words had changed their lives — and, in some cases, saved them. Many LGBTQ+ fans said Gibson’s poetry helped them learn to love themselves. People with cancer and other terminal illnesses said Gibson made them less afraid of death by reminding them that we never really leave the ones we love.

    In a poem Gibson wrote shortly before they died, titled “Love Letter from the Afterlife,” they wrote: “Dying is the opposite of leaving. When I left my body, I did not go away. That portal of light was not a portal to elsewhere, but a portal to here. I am more here than I ever was before.”

    Linda Williams Stay was “awestruck” when her son, Aiden, took her to hear Gibson perform at a bar in San Francisco a decade ago. Their poetry was electrifying, lighting up the room with laughter, tears and love. Gibson’s poetry became a shared interest for the mother and son, and eventually helped Stay better understand her son when he came out as transgender.

    “My son this morning, when he called, we just sobbed together,” Stay said. “He says, ‘Mom, Andrea saved my life.’”

    “I know,” she responded.

    Gibson’s poetry later helped Stay cope with a cancer diagnosis of her own, which brought her son back home to St. George, Utah, to help take care of her. They were delighted when Gibson accepted their invitation to perform at an event celebrating the LGBTQ+ community in southern Utah.

    “It was truly life-changing for our community down there, and even for our allies,” Stay said. “I hope that they got a glimpse of the magnitude of their impact for queer kids in small communities that they gave so much hope to.”

    Gibson was born in Maine and moved to Colorado in the late 1990s, where they had served the past two years as the state’s poet laureate. Their books included You Better Be Lightning, Take Me With You and Lord of the Butterflies.

    Colorado Gov. Jared Polis said Monday that Gibson was “truly one of a kind” and had “a unique ability to connect with the vast and diverse poetry lovers of Colorado.”

    In a 2017 essay published in Out magazine, Gibson remembered coming out at age 20 while studying creative writing at Saint Joseph’s College of Maine, a Catholic school. Identifying as genderqueer, Gibson wrote that they didn’t feel like a boy or a girl and cited a line of their poetry: “I am happiest on the road/ When I’m not here or there — but in-between.”

    Comedian Tig Notaro, an executive producer on the documentary and Gibson’s friend of 25 years, shared on Instagram how the two came up together as performers in Colorado. Hearing Gibson perform for the first time was like witnessing the “pure essence of an old-school genuine rock star,” and their words have guided Notaro through life ever since, she said.

    “The final past few days of Andrea’s life were so painful to witness, but simultaneously one of the most beautiful experiences of all of our lives,” Notaro said. “Surrounded by real human connection unfolding in the most unlikely ways during one of the most devastating losses has given me a gift that I will never be able to put into meaningful words.”

    Gibson’s illness inspired many poems about mortality, depression, life and what happens next. In the 2021 poem “How the Worst Day of My Life Became My Best,” Gibson declared “When I realized the storm/was inevitable, I made it/my medicine.” Two years later, they wondered: “Will the afterlife be harder if I remember/the people I love, or forget them?”

    “Either way, please let me remember.”

    Continue Reading

  • July 17 at Best Buy stores in the US

    July 17 at Best Buy stores in the US

    The next Best Buy Nintendo Switch 2 restock is timed with Best Buy on July 17 in stores (Image credit: Matt Swider / The Shortcut)
    • 🏷️ The next Nintendo Switch 2 restock will be in Best Buy stores in the US

    • 📆 Date & time: Friday, July 17, when your local Best Buy opens its doors

    • 🍌 Nintendo’s Donkey Kong Bananza also comes out on the same day

    • 🌟 Walmart’s Switch 2 and Switch 2 bundle should be in stock in late July, too

    • 🚨 Priority Alerts: The Shortcut subscribers get 1:1 help in our Substack Chat

    • 🔔 Turn on notifications for Matt Swider on X to get additional alerts

    Best Buy has confirmed that its next Switch 2 restock will take place on July 17, 2025, a date that holds special significance for Nintendo fans awaiting the return of Donkey Kong.

    Both the Best Buy Switch 2 and the Switch 2 bundle will be in stock in stores on July 17 when your local Best Buy store opens in the morning. The console restock will be in “limited quantities” at every store in the United States, according to an official Best Buy statement.

    Want a leg up? The Shortcut subscribers get early notifications when US stores have Switch 2 in stock. Our Substack Chat has the fastest links to buy it.

    Matt Swider restock alerts
    Twitter/X is still a great way to get our pre-order tracking alerts on your phone

    The timing of this week’s Best Buy Switch 2 restock coincides with the launch of the next big first-party Nintendo game, Donkey Kong Banaza, which launches on July 17.

    The strategy behind Best Buy’s decision is to sell as many Switch 2 consoles as possible on Friday, then upsell customers in the US on the $69 video game and the best Switch 2 accessories in stores. Retailers make very little money on console hardware, so Best Buy’s plan is to pitch US consumers on Switch 2 launch games, cameras, and controllers.

    Best Switch 2 games

    Just in case you don’t want to travel to a Best Buy store in person on July 17, Walmart won’t be far behind with its next online Switch 2 restock. It’s expected to happen toward the end of this month, according to the increasingly frequent timing of the console.

    Walmart has had the most Nintendo Switch 2 restock opportunities in the US and also the largest quantities. And it does quick deliveries right to your doorstep. Of course, you have to be quick to purchase the console, as it’s available on a first-come, first-served basis.

    Amazon, meanwhile, saw its first wave of invites to buy the console at the tail end of its Prime Day sales marathon. It’s more of a lottery system

    Continue Reading

  • David Kaff, Spinal Tap keyboardist and musician, dies aged 79 | This Is Spinal Tap

    David Kaff, Spinal Tap keyboardist and musician, dies aged 79 | This Is Spinal Tap

    David Kaff, the British actor and musician known for playing keyboardist Viv Savage in Rob Reiner’s 1984 mockumentary This Is Spinal Tap, has died aged 79.

    His bandmates in Mutual of Alameda’s Wild Kingdom confirmed the news on their Facebook page, writing that the musician had “passed away peacefully in his sleep” on Friday.

    “David always had a kind word and a quick wit that would slay you where you stand. Then he’d make you smile doing it!” they wrote. “RIP dear brother.”

    Born David Kaffinetti in Folkestone, Kaff studied classical piano as a child before falling in love with rock’n’roll in his teens. In his early 20s, he co-founded prog rock group Rare Bird, perhaps best known for their 1969 track Sympathy.

    However, he found greater fame playing the keys in This Is Spinal Tap’s fictional heavy metal band, alongside the movie’s co-writers Christopher Guest, Michael McKean and Harry Shearer. His memorable lines in the film include Viv’s life philosophy: “Have a good time … all the time.”

    This Is Spinal Tap stars David Kaff (centre) and Christopher Guest (right). Photograph: Authorized Spinal Tap LLC/Shutterstock

    Kaff performed as part of Spinal Tap at various gigs after the film’s release, including their appearance on Saturday Night Live, but by the end of 1984, he had left the group.

    He played in various other bands in the subsequent decades, including Oakland’s Model Citizens and San Francisco’s Mutual of Alameda’s Wild Kingdom – but Kaff remained fond of Spinal Tap and appreciative of fans’ love for his character in the movie.

    “I played him [Viv] very close to my heart, just a little bit dimmer,” he told BAM in 1991. “If people like that character, chances are they’ll like me.”

    A sequel to Spinal Tap, directed by Reiner and co-written by and starring McKean, Shearer and Guest, is due for release in September, but Kaff was not involved in the movie.

    Continue Reading

  • Industry Leaders Chart the Future of Mobile Innovation at Galaxy Tech Forum – Samsung Mobile Press

    Industry Leaders Chart the Future of Mobile Innovation at Galaxy Tech Forum – Samsung Mobile Press

    At Galaxy Unpacked 2025 on July 9, Samsung Electronics unveiled its latest Galaxy Z series devices and wearables — pushing the boundaries of foldable design and connected wellness experiences. These innovations mark the next step in the company’s mission to deliver meaningful, user-centered technology, with Galaxy AI and digital health emerging as key pillars of the journey ahead.

    To explore these themes further, Samsung hosted two panels at the Galaxy Tech Forum on July 10 in Brooklyn. Samsung Newsroom joined industry leaders and executives to examine how ambient intelligence and advanced health technologies are shaping the future of mobile innovation.

     

    ▲ (From left) Moderator Sabrina Ortiz, Jisun Park, Mindy Brooks and Dr. Vinesh Sukumar

     

    The first panel, “The Next Vision of AI: Ambient Intelligence,” explored how multimodal capabilities are enabling the continued evolution of AI in everyday life — blending into user interactions in ways that feel intuitive, proactive and nearly invisible. Panelists discussed the smartphone’s evolving role, the importance of platform integration and the power of cross-industry collaboration to deliver secure, personalized intelligence at scale.

    Jisun Park, Corporate Executive Vice President and Head of Language AI Team, Mobile eXperience (MX) Business at Samsung Electronics, opened the conversation by reflecting on Galaxy AI’s rapid adoption. Since the launch of the Galaxy S25 series in January, more than 70% of users have engaged with Galaxy AI features. He then turned the discussion to the next frontier, ambient intelligence — AI that is deeply personal, predictive and ever-present.

     

    News Body for

    ▲ Jisun Park from Samsung Electronics


    Samsung sees ambient intelligence as AI that is so seamlessly integrated into daily life it becomes second nature. The company is committed to democratizing Galaxy AI to 400 million devices by the end of 2025.

    This vision builds on insights from a yearlong collaboration with London-based research firm Symmetry, which revealed that 60% of users want their phones to anticipate needs without prompts — based on daily habits.

    “Some see AI as the start of a ‘post-smartphone’ era, but we see it differently,” said Park. “We’re building a future where your devices don’t just respond — they become smarter to anticipate, see and work quietly in the background to make life feel a little more effortless.”

    Mindy Brooks, Vice President of Android Consumer Product and Experience at Google, discussed how multimodal AI is moving beyond reactive response to deeper understanding of user intent across inputs like text, vision and voice. Google’s Gemini is designed to be intelligently aware and anticipatory — tuned to individual preferences and routines for assistance that feels natural.

    News Body for

    ▲ Mindy Brooks from Google

    “Through close collaboration with Samsung, Gemini works seamlessly across its devices and connects with first-party apps to provide helpful and personalized responses,” she said.

    Dr. Vinesh Sukumar, Vice President of Product Management at Qualcomm Technologies emphasized that as AI becomes more personalized, there is more information than ever that needs to be protected.

    “For us, privacy, performance and personalization go hand in hand — they’re not competing priorities but co-equal standards,” he said.

     

    News Body for

    ▲ Dr. Vinesh Sukumar from Qualcomm Technologies

     

    Both Brooks and Dr. Sukumar reinforced the importance of tight integration across platforms and hardware.

    “Our work with Samsung prioritizes secure, on-device intelligence so that users know where their data is and who controls it,” said Dr. Sukumar.

     

    News Body for

    ▲ The AI panel at Galaxy Tech Forum

     

    Moderator Sabrina Ortiz, senior editor at ZDNET, closed the session with a discussion on AI privacy. Panelists agreed that trust, transparency and user control must underpin the entire AI experience.

    “When it comes to building more agentic AI, our priority is to ensure we’re fostering smarter, more personalized and more meaningful assistance across our device ecosystem,” said Brooks.

     

     

    (Panel Two) The Next Chapter of Health: Scaling Prevention and Connected Care

    The second panel, “The Next Chapter of Health: Scaling Prevention and Connected Care,” focused on how technology can bridge the gap between wellness and clinical care — making health insights more connected, proactive and usable for individuals, healthcare providers and digital health solution partners. Panelists explored how the convergence of clinical data, at-home monitoring and AI is reshaping the modern healthcare experience.

     

    News Body for

    ▲ (From left) Moderator Dr. Hon Pak, Mike McSherry, Dr. Rasu Shrestha and Jim Pursley

     

    Health data is often siloed across systems, resulting in inefficiencies and gaps in care. Combined with rising rates of chronic illness, an aging population and ongoing clinician shortages, the result is a system under pressure to deliver timely, effective care.

     

    News Body for

    ▲ Dr. Hon Pak from Samsung Electronics

    “Patients and consumers around the world are asking us to hear them, to know them, to truly understand them,” said moderator Dr. Hon Pak, Senior Vice President and Head of Digital Health Team at Samsung Electronics. “And I believe this is the opportunity we have with Samsung, Xealth and partners like Hinge and Advocate. Together, we are creating a connected ecosystem where healthcare can truly make a difference — not just in the life of a patient, but in the life of a person.”

    Samsung is addressing this challenge through technological innovation and its recent acquisition of Xealth, a leading digital health platform with a network of more than 500 hospitals and 70 digital health solution providers. Through Xealth, Samsung plans to connect wearable data and insights from Samsung Health into clinical workflows — delivering a more unified and seamless healthcare experience.

    News Body for

    ▲ Mike McSherry from Xealth

    “This [phone], plus your devices — the watch, the ring — are going to replace the standalone blood pressure monitor, the pulse oximeter, a variety of different devices,” said Mike McSherry, founder and CEO of Xealth. “It’s going to be one packaged solution, and that’s going to simplify care.”

    This collaboration is designed to empower hospitals with real-time insights and help prevent chronic conditions through early detection and continuous monitoring with wearable devices.

    News Body for

    ▲ Dr. Rasu Shrestha from Advocate Health/p>


    “The reality is that with all of the challenges that exist in healthcare, it is not any one entity that can heroically go in and save healthcare. It really takes an ecosystem,” said Dr. Rasu Shrestha, Executive Vice President and Chief Innovation & Commercialization Officer at Advocate Health. “That’s part of the reason why I’m so excited about Xealth and Samsung — and partners like us — really coming together to solve for this challenge. Because it is about Samsung enabling it. It’s more of an open ecosystem, a curated ecosystem.”

    The panel spotlighted the growing shift from hospital-based care to care at home — and the opportunities enabled by Samsung’s expanding ecosystem of connected devices. Data from wearables, including those equipped with Samsung’s BioActive Sensor technology, can provide high-quality input for AI-driven insights.

    Paired with Samsung’s SmartThings connectivity and wide portfolio of smart home devices, the company is uniquely positioned to support remote health monitoring and treatment from home.

    AI is expected to play a role in reducing clinician workload by streamlining administrative tasks and surfacing the most relevant insights at the right time. Platforms like Xealth offer users a personalized, friendly interface to access necessary information from one place for a more connected healthcare experience.

    News Body for

    ▲ The health panel at Galaxy Tech Forum/p>

     

    Across both sessions, one theme was clear — realizing the potential of ambient intelligence and scaling prevention and connected care requires deep, cross-industry collaboration.

    From on-device privacy solutions like Knox Matrix to expanded integration across Galaxy devices, Samsung and its partners are building an ecosystem that’s not only intelligent but simple, secure and future-ready.

     

    Continue Reading